Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Establishment of a novel diagnostic model for Sjögren's syndrome (pSS) by proteomic fingerprinting.

sjogrens diagnosis

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 16 November 2014 - 03:50 AM

Establishment of a novel diagnostic model for Sjögren's syndrome (pSS) by proteomic fingerprinting.

 

Proteomic fingerprinting was able to distinguish pSS from non-pSS controls with a sensitivity of 77.1 % and a specificity of 85.5 %, and was effective in the diagnosis of pSS. PubMed, Clin Rheumatol, 2014 Sep 2. (Also see: Diagnosis of Sjogren's Syndrome)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)